Ashley Titchenal
Primary Care · Saint Louis, MONPI 1609411784
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,528 of the $3,348 with a category attached, or 75.5%. 28 manufacturers reported payments, led by Solventum Corporation at 29.7% of the total. Reporting peaked in 2024 at $1,315 and has fallen 93.8% since, to $81 in 2025. Among primary care clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $34.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Solventum Corporation$995
- Novartis$399
- Boehringer Ingelheim$240
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$193
- Cvrx, Inc.$151
- Amgen$150
- plus $1K from 22 others
What the payments were for
- Travel & lodging$82024%
- Food & beverage$2,52876%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Solventum Corporation | 5 | $995 |
| Novartis | 39 | $399 |
| Boehringer Ingelheim | 7 | $240 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $193 |
| Cvrx, Inc. | 4 | $151 |
| Amgen | 3 | $150 |
| Integra Lifesciences Corporation | 3 | $126 |
| E.r. Squibb & Sons, L.L.C. | 1 | $118 |
| KCI USA, Inc. | 1 | $117 |
| Bayer | 2 | $94 |
| Amarin Pharma, Inc. | 6 | $90 |
| Scpharmaceuticals Inc. | 1 | $87 |
| Impulse Dynamics (USA) Inc. | 1 | $86 |
| Kestra Medical Technology Services, Inc. | 1 | $84 |
| Polynovo North America LLC | 1 | $81 |
| Lexicon Pharmaceuticals, Inc. | 1 | $76 |
| Boston Scientific | 2 | $40 |
| Pfizer | 1 | $34 |
| AstraZeneca | 2 | $31 |
| Merck | 1 | $25 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Convatec Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$934
- ABTHERA$495
- V.A.C. DERMATAC$378
- V.A.C. VERAFLO$378
- CAMZYOS$118
- Repatha$114
- JARDIANCE$104
How this compares
$3,348 in reported general payments places this provider in the 90th percentile of 106 primary care providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other primary care in Saint Louis
- Joy MurphySaint Louis$7K
- Kelly EspositoSaint Louis$6K
- Elizabeth YoungSaint Louis$5K
- Heather BealSaint Louis$4K
- Brittany ShoultsSaint Louis$3K
- Stella HeineSaint Louis$2K
- Johnathan WieseSaint Louis$2K
- Taylor RouserSaint Louis$2K
- Faye MonahanSaint Louis$1K
- Alita BillopsSaint Louis$840
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.